Clinical Trials Logo

Postoperative Delirium clinical trials

View clinical trials related to Postoperative Delirium.

Filter by:

NCT ID: NCT04193280 Recruiting - Clinical trials for Postoperative Delirium

Blood Sugar Level and Postoperative Agitations in Pediatric Surgery

Start date: November 1, 2019
Phase:
Study type: Observational

The aim of this study is to investigate the effect of fasting time and blood glucose levels on postoperative agitations in pediatric patients who will undergo outpatient surgery.

NCT ID: NCT04154176 Completed - Clinical trials for Postoperative Delirium

Validation of the Greek Version of the Confusion Assessment Method Diagnostic Algorithm (CAM) and the Nursing Delirium Screening Scale (Nu-DESC) and Their Inter-rater Reliablity

Start date: September 1, 2019
Phase:
Study type: Observational

This study attempts to validate the Greek version of the CAM Diagnostic Algorithm and Nu-DESC in patients undergoing surgery under general anesthesia.

NCT ID: NCT04092894 Recruiting - Insomnia Clinical Trials

Suvorexant and Sleep/Delirium in ICU Patients

Start date: February 28, 2020
Phase: Phase 4
Study type: Interventional

Investigators will evaluate the efficacy of postoperative oral suvorexant treatment on nighttime wakefulness after persistent sleep onset (WASO) among adult cardiac surgical patients recovering in the cardiac intensive care unit (ICU). The study include patients ≥ 60 years old undergoing coronary artery bypass graft surgery (CABG), with or without valve surgery (aortic or mitral). Patients will receive either oral suvorexant or placebo for 7 nights starting the night after extubation. The primary hypothesis is that suvorexant compared with placebo decreases WASO, as measured by a specialized electroencephalogram (EEG), the SedLine monitor, during the first night in the cardiac ICU. Investigators will also assess total sleep time (TST), time to sleep onset (TSO), and postoperative delirium and delirium-free days.

NCT ID: NCT04056871 Completed - Clinical trials for Postoperative Delirium

Different Frailty Scores to Incidence of Post-operative Delirium and Cognitive Dysfunction

Start date: August 20, 2019
Phase:
Study type: Observational

Patients who are frail will have higher rate for post-operative morbidities, mortality, prolonged hospital stays, loss of independence, increase in institutionalization, post-operative cognitive dysfunction (POCD) and delirium (POD). So, it is crucial to find a suitable frailty assessment tool that can be incorporated into a guideline and reference for our local setting in geriatric peri-operative management. In the mean time, create awareness regarding the frailty elderly population with POD, POCD and other associated poor outcomes among our clinicians.

NCT ID: NCT04027751 Recruiting - Clinical trials for Postoperative Delirium

The Efficacy and Safety of Tropisetron in Preventing Emergence Delirium

Start date: August 1, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of Tropisetron in preventing emergence delirium.

NCT ID: NCT04009200 Completed - Clinical trials for Postoperative Delirium

The Effect of Preoperative Anxiety on Postoperative Delirium in Children

Start date: March 1, 2018
Phase:
Study type: Observational [Patient Registry]

Investigation of the effect of preoperative anxiety on postoperative delirium in children who will undergo circumcision operation

NCT ID: NCT03982953 Recruiting - Parkinson's Disease Clinical Trials

Predicting Cognition After DBS for Parkinson's Disease

Start date: June 12, 2019
Phase:
Study type: Observational

The aim of the study is to improve estimation of cognitive outcome after STN-DBS in PD in order to - avoid risk factors by optimizing peri- and intraoperative management - personalize therapeutic strategies for optimal long-term benefit The investigators will test possible predictors (clinical, neuropsychological, neuroimaging, electrophysiological and molecular) for the risk of cognitive dysfunction after deep brain stimulation of the subthalamic nucleus (STN-DBS) in Parkinson's disease (PD) at a single center (Charité - Universitätsmedizin Berlin, Germany). Data collection takes place prior to as well as 3 and 12 months after the STN-DBS operation. Participation is proposed to all PD patients that are planned to undergo STN-DBS after careful examination of eligibility for this treatment according to standard operation procedures.

NCT ID: NCT03968887 Not yet recruiting - Clinical trials for Postoperative Delirium

Correlation Between Plasma Oxidized Low Density Lipoprotein Levels And Postoperative Delirium

Start date: May 20, 2019
Phase:
Study type: Observational [Patient Registry]

Postoperative delirium (POD) refers to an acute neurocognitive disorder that occurs within 1 week after surgery or before discharge. Old age is one of the important risk factors for postoperative delirium. The incidence rate of the elderly is high, and the life span of human beings is increasing. Postoperative delirium has adverse effects on both short-term and long-term outcomes, including mortality, ability to work, and dependence on society. Low-density lipoprotein (LDL) is a key molecule in the cholesterol transport mechanism and is easily oxidized to oxidized low-density lipoprotein (OxLDL). Oxidized low density lipoproteins are immunogenic and are also cytotoxic to endothelial cells. Some studies have shown that increased oxidative stress is one of the earliest changes in disease, and similar signs can be detected in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI), such as protein oxidation and lipids. An increase in the quality of the peroxidation index. For the study of anesthesiology, oxidative stress theory has long been recognized as one of the mechanisms of postoperative delirium. We have a hypothesis that plasma oxidized low-density lipoprotein levels are associated with postoperative delirium and can be used as an early warning marker for disease occurrence. Based on clinical research data, we conducted a prospective cohort study to explore the correlation between plasma oxidized low-density lipoprotein levels and postoperative sputum, providing clinical prediction and diagnostic value.

NCT ID: NCT03950440 Completed - Clinical trials for Aortic Valve Stenosis

Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement

IPOD-AV
Start date: September 23, 2018
Phase:
Study type: Observational

Our primary aim in this observational study is to identify the incidence of POD in the first five postoperative days by using the 3-minute Diagnostic confusion assessment method (3D-CAM), the derived version for intensive care unit (CAM-ICU) or nurse reports in patients undergoing different techniques of aortic valve replacement. Patients are followed 5 days postoperative with the 3D-CAM or until resolution of POD. Six months postoperatively, a follow-up by phone is planned for activity of daily living (ADL).

NCT ID: NCT03931499 Recruiting - Clinical trials for Postoperative Delirium

Biochemical Predictors of Delirium in Cardiac Surgery

Start date: June 10, 2019
Phase:
Study type: Observational

Delirium is a common neurologic complication after cardiac surgery occuring in 30-50% of patients. The occurence of this complication is associated with worse outcomes, including prolonged length of stay in the ICU and hospital, increased morbidity and mortality. Considering great clinical significance of this complication, the search for early predictors of postoperative delirium remains an urgent task. The purpose of this prospective observational study is to test the hypothesis that metabolomic changes before and after cardiac surgery could be served as early predictors of this complication.